Results 131 to 140 of about 3,490 (181)

RET Signaling Pathway in Human Cancer: Oncogenic Mechanisms, Selective Inhibitors, and Emerging Resistance Strategies. [PDF]

Int J Mol Sci
Streit S, Dweik A, Mahtab A, Ali S, Khan A, Salzberg M.   +5 more
europepmc   +1 more source

Genomic testing for RET in the clinic: UK and global perspective. [PDF]

Endocr Relat Cancer
Izatt L.
europepmc   +1 more source

RET@Thirty: the story behind identification of RET mutation as the cause of MEN2 and what it meant to clinical practice. [PDF]

Endocr Relat Cancer
Ponder B, Kurzawinski TR.
europepmc   +1 more source

Diagnostic Lag in Precision Medicine. [PDF]

Clin Pharmacol Ther
Heneberg P.
europepmc   +1 more source

Outcomes of pediatric prophylactic thyroidectomy in MEN2: A systematic review

International Journal of Pediatric Otorhinolaryngology
Ina Lee, Zachary Pierre, Christopher Naranjo, Rahul Sharma, Dylan K. Thompson, Sara Bartz, Monica E. Lopez, Ryan H. Belcher   +7 more
openaire   +1 more source

Parathyroid autotransplantation: a phase-based framework for surgical decision-making. [PDF]

Front Endocrinol (Lausanne)
Tu H, Jiang Y, Jiang T, Yang Y, Su A.
europepmc   +1 more source

MEN2 syndrome - medullary thyroid cancer and pheochromocytoma

, 2016
openaire   +1 more source

A Rare Case of Coexisting Medullary and Papillary Thyroid Carcinomas With Parathyroid Adenoma in Pancreatic Neuroendocrine Tumour (pNET). [PDF]

Cureus
Salam NB, Tithi F, Zachariah S.
europepmc   +1 more source

Metachronous contralateral pheochromocytoma detected 62 years after initial surgery. [PDF]

JCEM Case Rep
Kawabe Y, Ozaki K, Niinomi A, Katsumata M, Nakaue J, Takahashi Y.   +5 more
europepmc   +1 more source

Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification. [PDF]

Front Endocrinol (Lausanne)
Jia C, Guo S, Wu K, Wang Y, Yang S, Wang L, Chen T, Meng X.   +7 more
europepmc   +1 more source